"Tyzeka has cross resistance issues and isn't differentiated."
Well that never appeared in the read-me-first - you may go back and search for various versions of it. Point-of-fact I requested Dew to insert this very issue in there around 18 months ago, but he ignored my post.
"That obviously existed from day one. Poorly thought of by everyone."
Well I would refer you to past read-me-firsts here, as well as the stock price a couple of years ago. And even recently, you will find material here that reflects a challenge to the market leader -
Well I don't like some of them either, but I do like their drugs, or else I like their stock price.....I can't be wrong about all of them, so you should look closer, IMHO.